Breaking News Instant updates and real-time market news.

HOLX

Hologic

$41.22

0.13 (0.32%)

05:14
07/10/18
07/10
05:14
07/10/18
05:14

Hologic checks suggest Cynosure has recovered, says Piper Jaffray

Piper Jaffray analyst William Quirk says his Q3 channel checks suggest Hologic's Cynosure unit "may have finally turned the corner." Given the negative sentiment surrounding Hologic shares, now is a good time to add to positions, Quirk tells investors in a research note. The analyst now has eight months of weekly data on Cynosure and competitive lasers for sale at secondhand websites. Overall, aggregated used lasers on third party web resellers was down to 162 lasers from 179 in the March and December quarters, he points out. Quirk keeps an Overweight rating on Hologic with a $48 price target.

  • 12

    Jul

  • 31

    Jul

  • 21

    Aug

  • 27

    Aug

HOLX Hologic
$41.22

0.13 (0.32%)

05/03/18
05/03/18
DOWNGRADE
Target $41

Market Perform
Hologic downgraded to Market Perform at Leerink
As previously reported, Leerink analyst Richard Newitter downgraded Hologic to Market Perform from Outperform as his conviction in near-term EPS estimate upside has diminished, especially now that its tax-benefit related "EPS cushion" is basically getting used to mitigate Hologic's reduced sales outlook. The analyst also lowered his price target on the shares to $41 from $48.
05/03/18
05/03/18
DOWNGRADE
Target $39

Hold
Hologic downgraded to Hold at Canaccord
As previously reported, Canaccord analyst Mark Massaro downgraded Hologic to Hold from Buy and lowered his price target on the shares to $39 from $48. In a pre-open research note, the analyst said Hologic "has started off on the wrong foot this year, a clear disappointment," and it is unclear to him that resetting the guide changes the fact that Cynosure does not appear to have a near-term catalyst to stabilize the segment, nor does he have conviction it can achieve its goal of double-digit growth anytime soon. Massaro also removed Hologic as one of his top 5 picks for 2018.
05/25/18
EVER
05/25/18
NO CHANGE
Target $40.5
EVER
Outperform
Hologic relationship with Quest seems 'healthy,' says Evercore ISI
Evercore IS analyst Vijay Kumar sees "minimal risks" to Hologic (HOLX) from Quest Diagnostics' (DGX) and LabCorp's (LH) contract renegotiations with UnitedHealth (UNH) and Aetna (AET). He estimates Quest and LabCorp together account for about $200M of revenue for Hologic. Hologic received a Supplier Excellence award last year from Quest, which points to "healthy" relationship, Kumar tells investors in a research note. He believes the labs' new contracts bake in a mid-single digit pricing cut, leading a "manageable" 3c-4c of earnings impact to Hologic. Kumar has an Outperform rating on the shares with a $40.50 price target.
07/03/18
LEHM
07/03/18
NO CHANGE
Target $50
LEHM
Overweight
FDA update positive for near-term Hologic results, says Barclays
The FDA yesterday afternoon published its June update on industry mammography trends, which included "solid" 3D placements of 121, Barclays analyst Jack Meehan tells investors in a research note. The analyst believes the data are encouraging for near-term results for Hologic in the Breast Health segment. It also helps to show the sustainability of the "tomo tail" with Hologic approaching 60% conversion of its installed base, Meehan contends. He keeps an Overweight rating on Hologic with a $50 price target.

TODAY'S FREE FLY STORIES

XERS

Xeris Pharmaceuticals

$18.26

-0.18 (-0.98%)

06:53
07/16/18
07/16
06:53
07/16/18
06:53
Initiation
Xeris Pharmaceuticals initiated  »

Xeris Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INST

Instructure

$44.93

-0.225 (-0.50%)

06:53
07/16/18
07/16
06:53
07/16/18
06:53
Initiation
Instructure initiated  »

Instructure initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 30

    Jul

BAC

Bank of America

$28.54

-0.24 (-0.83%)

06:53
07/16/18
07/16
06:53
07/16/18
06:53
Hot Stocks
Bank of America CEO says solid operating leverage drove earnings in Q2 »

Brian Moynihan, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

USO

United States Oil Fund

$14.47

0.085 (0.59%)

06:53
07/16/18
07/16
06:53
07/16/18
06:53
Technical Analysis
United States Oil Fund: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIIV

i3 Verticals

$16.73

-0.025 (-0.15%)

06:52
07/16/18
07/16
06:52
07/16/18
06:52
Initiation
i3 Verticals initiated  »

i3 Verticals initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$17.14

0.08 (0.47%)

06:52
07/16/18
07/16
06:52
07/16/18
06:52
Conference/Events
Krystal Biotech management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 25

    Jul

XOP

SPDR Oil Exploration and Production Fund

$43.19

0.06 (0.14%)

06:52
07/16/18
07/16
06:52
07/16/18
06:52
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$28.54

-0.24 (-0.83%)

06:51
07/16/18
07/16
06:51
07/16/18
06:51
Hot Stocks
Bank of America reports Q2 average loan balances in business segments up 5% »

Average loan balances in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$26.43

0.89 (3.48%)

06:51
07/16/18
07/16
06:51
07/16/18
06:51
Technical Analysis
VelocityShares 3x Inv Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$102.95

0.17 (0.17%)

, TEVA

Teva

$23.29

-0.45 (-1.90%)

06:51
07/16/18
07/16
06:51
07/16/18
06:51
Recommendations
Neurocrine, Teva analyst commentary  »

Neurocrine price target…

NBIX

Neurocrine

$102.95

0.17 (0.17%)

TEVA

Teva

$23.29

-0.45 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 10

    Sep

  • 16

    Sep

UGAZ

VelocityShares 3x Long Natural Gas ETN

$54.61

-2.06 (-3.64%)

06:50
07/16/18
07/16
06:50
07/16/18
06:50
Technical Analysis
VelocityShares 3x Long Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$28.54

-0.24 (-0.83%)

06:50
07/16/18
07/16
06:50
07/16/18
06:50
Hot Stocks
Bank of America reports Q2 NII up 6% to $11.7B »

Reflecting benefits from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

ERJ

Embraer

$21.50

-0.78 (-3.50%)

06:49
07/16/18
07/16
06:49
07/16/18
06:49
Periodicals
Embraer sees demand for 10,550 smaller jets in next 20 years, Reuters reports »

Brazil's Embraer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

EPRT

Essential Properties Realty Trust

$14.00

(0.00%)

06:49
07/16/18
07/16
06:49
07/16/18
06:49
Initiation
Essential Properties Realty Trust initiated  »

Essential Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWZ

MSCI Brazil Index

$34.05

0.67 (2.01%)

06:49
07/16/18
07/16
06:49
07/16/18
06:49
Technical Analysis
MSCI Brazil Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNTR

Venator Materials

$16.76

0.07 (0.42%)

, TROX

Tronox

$19.31

-0.28 (-1.43%)

06:49
07/16/18
07/16
06:49
07/16/18
06:49
Hot Stocks
Venator Materials to acquire European paper laminates business from Tronox »

Venator Materials (VNTR)…

VNTR

Venator Materials

$16.76

0.07 (0.42%)

TROX

Tronox

$19.31

-0.28 (-1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 08

    Aug

PSA

Public Storage

$228.07

-1.43 (-0.62%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Downgrade
Public Storage rating change  »

Public Storage downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

EFA

iShares MSCI EAFE Index Fund

$67.80

0.21 (0.31%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Technical Analysis
iShares MSCI EAFE Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$28.54

-0.24 (-0.83%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Hot Stocks
Bank of America reports Q2 return on average assets 1.17% »

Reports Q2 return on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

BRO

Brown & Brown

$28.76

0.025 (0.09%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Hot Stocks
Brown & Brown subsidiary acquires Professional Disability Associates »

J. Scott Penny, Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

JNK

SPDR Barclays High Yield Bond

$35.69

(0.00%)

06:48
07/16/18
07/16
06:48
07/16/18
06:48
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCI

Intra-Cellular

$20.45

-0.11 (-0.54%)

06:47
07/16/18
07/16
06:47
07/16/18
06:47
Conference/Events
Intra-Cellular management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SJB

ProShares Short High Yield

$22.95

-0.055 (-0.24%)

06:47
07/16/18
07/16
06:47
07/16/18
06:47
Technical Analysis
ProShares Short High Yield: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSUR

OraSure

$17.32

0.01 (0.06%)

06:46
07/16/18
07/16
06:46
07/16/18
06:46
Downgrade
OraSure rating change  »

OraSure downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

NEP

NextEra Energy Partners

$45.91

-0.51 (-1.10%)

06:46
07/16/18
07/16
06:46
07/16/18
06:46
Downgrade
NextEra Energy Partners rating change  »

NextEra Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.